Evidence map›Paper›PMID 36926648›Full record

ArticleHarvard data science review2022

The Family of Single-Case Experimental Designs.

Leonard H Epstein, Jesse Dallery

Abstract read
In one paragraph

Article in Harvard data science review, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Leonard H EpsteinJacobs School of Medicine and Biomedical Sciences, Division of Behavioral Medicine, Department of Pediatrics, University at Buffalo, Buffalo, New York, United States of America.
Jesse DalleryDepartment of Psychology, University of Florida, Gainesville, Florida, United States of America.

Funding

The Effectiveness of Family-based Weight Loss Treatment Implemented in Primary Care - CCC - Lead ApplicationU01HL131552 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI EPSTEIN, LEONARD H, WILFLEY, DENISE ELLA · 2016 to 2020
$8.9M
Re-engineering Precision Therapeutics Through N-of-1 TrialsR01LM012836 · NLM · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI DAVIDSON, KARINA W. · 2017 to 2023
$7.6M
Roybal Center for Personalized Trials: Physical Activity Promotion to Foster Healthy AgingP30AG063786 · NIA · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI Karina W. Davidson · 2020 to 2026
$6.7M
Can reinforcing alternatives to food prevent weight gain in children?R01HD088131 · NICHD · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI EPSTEIN, LEONARD H · 2016 to 2020
$2.8M
Using prospection to improve obesity treatmentR01HD080292 · NICHD · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI EPSTEIN, LEONARD H · 2015 to 2019
$2.8M
Delay discounting as a target for self-regulation in prediabetesUH3DK109543 · NIDDK · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BICKEL, WARREN K, EPSTEIN, LEONARD H · 2018 to 2019
$2.0M
NHLBI NIH HHS U01 HL131552NIA NIH HHS P30 AG063786NICHD NIH HHS R01 HD080292NICHD NIH HHS R01 HD088131NIDDK NIH HHS UH3 DK109543NLM NIH HHS R01 LM012836
6 · The paper itself

Abstract

Single-case experimental designs (SCEDs) represent a family of research designs that use experimental methods to study the effects of treatments on outcomes. The fundamental unit of analysis is the single case-which can be an individual, clinic, or community-ideally with replications of effects within and/or between cases. These designs are flexible and cost-effective and can be used for treatment development, translational research, personalized interventions, and the study of rare diseases and disorders. This article provides a broad overview of the family of single-case experimental designs with corresponding examples, including reversal designs, multiple baseline designs, combined multiple baseline/reversal designs, and integration of single-case designs to identify optimal treatments for individuals into larger randomized controlled trials (RCTs). Personalized N-of-1 trials can be considered a subcategory of SCEDs that overlaps with reversal designs. Relevant issues for each type of design-including comparisons of treatments, design issues such as randomization and blinding, standards for designs, and statistical approaches to complement visual inspection of single-case experimental designs-are also discussed.

Indexed as

multiple baseline designspersonalized medicinereversal designssingle-case experimental designs

Identifiers

PMID36926648
PMCPMC10016625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.